《新股消息》维亮控股(08612.HK)发售价上限0.55元定价一手中签率35%
明日挂牌上市的维亮控股(08612.HK)公布配发结果,发售价定於0.55元,为其招股价区间(0.4-0.55元)上限,集资净额5,530万元,其中27.8%将用於购买新建筑机械,约18.6%将用於结算新购一台履带起重机应付之剩余代价金额,约2.7%将用於招募及扩大技术人员团队,约41%将用於偿还银行借贷及融资租赁,其余9.9%将用作一般营运资金。
公开发售部份录得28.19倍认购,经重新分配後,公开发售股份的最终数目为4,500万股,相当於根据股份发售可供认购发售股份总数的30%。一手中签率35.01%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.